CanaQuest Achieves Statistically Significant Reduction of Seizures for Epilepsy Compared to Standard CBD

CanaQuest Achieves Statistically Significant Reduction of Seizures for Epilepsy Compared to Standard CBD

Drug Candidate, CQ-001 (cannabidiol “CBD” + IP system), also demonstrated considerably diminished seizures at better doses, with fewer CBD, in comparison to typical CBD. TORONTO, ON / ACCESSWIRE / December 8, 2022 / CANAQUEST Clinical CORP (OTC PINK:CANQF) (the “Company” or “CanaQuest“), a scientific-phase daily life sciences company focused on drug discovery and progress of […]

Medical Marijuana, Inc. Celebrates Largest Revenue Month of 2022 in April, Japan Division Achieves Best Revenue Month in History of the Company

Medical Marijuana, Inc. Celebrates Largest Revenue Month of 2022 in April, Japan Division Achieves Best Revenue Month in History of the Company

Medical Marijuana, Inc. SAN DIEGO, CA, Might 12, 2022 (Globe NEWSWIRE) — through NewMediaWire – Healthcare Marijuana, Inc. (OTC: MJNA) (the “Company”), the 1st-at any time publicly traded hashish company in the United States that released the world’s first-ever cannabis-derived nutraceutical merchandise, brands, and provide chain, introduced now that in April, the Company has achieved […]